Author:
Raffi François,Orkin Chloe,Clarke Amanda,Slama Laurence,Gallant Joel,Daar Eric,Henry Keith,Santana-Bagur Jorge,Stein David K.,Bellos Nicholaos,Scarsella Anthony,Yan Mingjin,Abram Michael E.,Cheng Andrew,Rhee Martin S.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Infectious Diseases
Reference16 articles.
1. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence;Hall;Am J Kidney Dis.,2011
2. Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system;Gupta;AIDS Patient Care STDS.,2008
3. Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral naive, HIV-1-infected adults: 48-week results from the ASSERT study;Post;J Acquir Immune Defic Syndr.,2010
4. Comparison of changes in bone density and turnover with abacavir–lamivudine versus tenofovir–emtricitabine in HIV-infected adults: 48-week results from the ASSERT study;Stellbrink;Clin Infect Dis.,2010
5. Bone health and human immunodeficiency virus infection;Schafer;Pharmacotherapy,2013
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献